Alpha-Lipoic Acid (ALA): Benefits for Neuropathy, Antioxidant Activity & Dosage Guide
⚡ 60-Second Summary
Alpha-lipoic acid (ALA) is a sulfur-containing fatty acid that functions as an essential cofactor for mitochondrial energy enzymes and as a potent antioxidant in both water-soluble and fat-soluble compartments of the cell. Unlike most antioxidants, ALA works in both aqueous and lipid environments and regenerates other antioxidants (vitamins C and E, glutathione, CoQ10).
Best-evidenced uses: Diabetic peripheral neuropathy — the strongest indication, with multiple RCTs showing intravenous and oral ALA reduce neuropathic pain and improve nerve function. Also studied for blood glucose control, oxidative stress reduction, and weight management (more modest effects).
Practical note: R-ALA (the natural enantiomer) is biologically active; S-ALA (synthetic) is less potent. Racemic ALA (50:50 mixture) is the most common supplement form. For maximum benefit, take on an empty stomach as food significantly reduces peak plasma levels. Start with 300–600 mg/day for neuropathy.
What is Alpha-Lipoic Acid (ALA)?
ALA is found in small amounts in foods (spinach, broccoli, organ meats) but at concentrations far below therapeutic doses. It is synthesized endogenously and serves as a cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase — central enzymes in the Krebs cycle. As an antioxidant, ALA scavenges reactive oxygen species and chelates transition metals (iron, copper, cadmium) that catalyze oxidative reactions.
ALA has been approved in Germany as a prescription drug for diabetic neuropathy since the 1960s. The ALADIN, SYDNEY, and NATHAN trials established intravenous ALA (600 mg/day) and oral ALA (1,200–1,800 mg/day) as effective treatments for neuropathic symptoms. Oral bioavailability is highly variable (30–40%) and significantly reduced by food.
Evidence-based benefits
1. Diabetic peripheral neuropathy
Multiple RCTs including the ALADIN, SYDNEY, and NATHAN trials demonstrate that ALA 600 mg IV or 600–1,800 mg oral per day significantly reduces neuropathic pain scores, paresthesia, and numbness compared to placebo in people with diabetic neuropathy.
2. Antioxidant and oxidative stress reduction
ALA reduces systemic markers of oxidative stress (8-OHdG, TBARS, F2-isoprostanes) in multiple human trials. It regenerates vitamins C, E, glutathione, and CoQ10, acting as a 'network antioxidant' that amplifies the entire antioxidant system.
3. Blood glucose and insulin sensitivity
Meta-analyses show ALA modestly reduces fasting blood glucose and HbA1c in people with type 2 diabetes, possibly through improved insulin signaling (AMPK activation). The effect size is modest compared to metformin.
4. Weight management (preliminary)
A meta-analysis of RCTs found ALA supplementation produces modest but significant weight loss (~1.5 kg) compared to placebo. Mechanism may involve AMPK-mediated appetite suppression. Not a primary weight loss intervention.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| Racemic ALA (50:50 R+S) | Moderate (30-40% absorbed fasting) | Cost-effective general supplementation | Most common supplement form. Take on empty stomach. 300–600 mg standard supplemental dose. |
| R-ALA (pure natural form) | Higher per mg than racemic | Maximum potency applications | More expensive; thermally unstable (some products use stabilized R-ALA-Na). Effective at lower doses than racemic. |
| Stabilized R-ALA (Na-R-ALA) | High | Maximum potency with stability | Sodium salt of R-ALA; more stable than free R-ALA; well absorbed. |
How much should you take?
- Diabetic neuropathy: 600 mg/day (IV) or 600–1,800 mg/day oral (RCT doses)
- General antioxidant supplementation: 300–600 mg/day
- Blood glucose support: 600–1,200 mg/day
- Take on empty stomach (food reduces absorption by ~30%)
- No established dietary RDA; no official UL
Take ALA at least 30 minutes before or 2 hours after a meal for maximum absorption. For doses above 600 mg/day, divide into 2–3 doses. Thiamine (B1) should be adequate as both support the same mitochondrial enzyme complexes.
Safety and side effects
Common side effects
- GI upset: nausea, stomach cramping — take with a small amount of food if intolerable
- Skin rash (rare; may indicate thiamine deficiency if occurring with high ALA doses)
- Hypoglycemia risk at high doses in people with diabetes on medications
- Fishy odor at very high doses
Serious risks
ALA is well-tolerated in clinical trials up to 1,800 mg/day oral. The most significant safety concern in diabetics is hypoglycemia — ALA can lower blood glucose, so people on insulin or oral hypoglycemics should monitor blood sugar carefully and discuss dose with their physician. ALA chelates certain minerals; avoid taking simultaneously with iron or other mineral supplements.
Drug and nutrient interactions
- Insulin and oral hypoglycemics (metformin, sulfonylureas) — ALA lowers blood glucose; additive hypoglycemia risk in people with diabetes; monitor blood glucose closely
- Thyroid medications (levothyroxine) — ALA may reduce thyroid hormone action; separate by at least 2 hours
- Chemotherapy (cisplatin, others) — ALA's antioxidant properties may theoretically interfere with oxidative mechanisms of some chemotherapies; discuss with oncologist
- Iron and mineral supplements — ALA chelates iron and other metals; separate supplementation by at least 2 hours
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| People with diabetic peripheral neuropathy seeking adjunct treatment | People with diabetes on insulin or hypoglycemics — monitor blood glucose closely |
| Adults with high oxidative stress or metabolic syndrome | People undergoing chemotherapy — discuss with oncologist first |
| Those seeking a network antioxidant to support other antioxidants | Pregnant or breastfeeding women — insufficient safety data at high doses |
Frequently asked questions
What is alpha-lipoic acid best for?
ALA has the strongest evidence for diabetic peripheral neuropathy, where multiple large RCTs show it reduces neuropathic pain and improves nerve function. It is also a potent antioxidant that regenerates vitamins C, E, and glutathione. Blood glucose and modest weight effects are secondary, smaller-magnitude benefits.
What is the difference between R-ALA and regular ALA?
Standard ALA supplements contain a 50:50 mixture of R-ALA (naturally occurring, more biologically active) and S-ALA (synthetic mirror image, less potent). Pure R-ALA is more effective per milligram but more expensive and less thermally stable. Stabilized R-ALA (sodium salt) combines potency with stability.
Does ALA cause hypoglycemia?
At high doses (600+ mg/day), ALA can lower blood glucose, which is beneficial for people with insulin resistance but potentially dangerous for people with diabetes on insulin or hypoglycemics. Monitor blood sugar carefully if you have diabetes and are taking ALA.
Should I take ALA with food?
For maximum absorption, take ALA on an empty stomach (30 min before meals). Food, especially fat, reduces peak plasma concentrations by about 30%. If GI side effects are a problem, a small amount of food can help without dramatically reducing absorption.
Can ALA help with weight loss?
A meta-analysis of RCTs found ALA produces approximately 1.5 kg more weight loss than placebo over several months, possibly through AMPK-mediated appetite suppression. The effect is real but modest — ALA should not be considered a primary weight loss intervention.
Related ingredients
Acetyl-L-Carnitine
Commonly combined with ALA for diabetic neuropathy — complementary mitochondrial support.
CoQ10
Another mitochondrial antioxidant with complementary mechanisms.
Acetyl-Glutathione
ALA regenerates glutathione; complementary antioxidant strategies.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.